The UK Vaccine Damage Payment Scheme (VDPS) isn't broken because it's underfunded or slow. It's broken because it was designed to be a firewall, not a safety net. While the chair of the Covid-19 Inquiry, Baroness Hallett, calls for an "urgent review" and "radical reform," she’s missing the structural reality of how public health insurance actually functions. We are currently witnessing a classic bureaucratic trap: trying to fix a 1979 relic with 2026 sensibilities. It won't work.
The "lazy consensus" suggests that if we simply lower the threshold for "severe disability" from 60% down to something more reasonable, or if we increase the measly £120,000 lump sum, justice will be served. This is a fantasy. Expanding the scheme without dismantling the evidentiary standards required to prove causation is like building a wider bridge that still leads to a cliff.
The 60% Threshold is a Feature Not a Bug
The loudest outcry centers on the 60% disability threshold. Critics call it arbitrary. They’re right. It is completely arbitrary, borrowed from the Industrial Injuries Disablement Benefit logic of the late 70s. But here is the part no one wants to admit: that threshold exists to prevent the scheme from becoming a general universal basic income for anyone who experiences a health decline after a medical intervention.
In medical terms, proving that a specific mRNA sequence or viral vector directly caused a specific neurological or cardiac event is a nightmare of statistical probability. Under the current system, the "balance of probabilities" (the 51% rule) is the legal standard, but in practice, the VDPS operates on a "certainty or bust" model.
If you lower the disability threshold to 20%, you don’t just triple the applicants; you quintuple the administrative friction. You create a backlog that lasts decades. The current system isn't failing by accident; it’s failing because the government cannot afford the precedent of admitting that rare side effects are a recurring cost of mass-scale public health.
The Myth of the "One-Off" Payment
The £120,000 figure is a joke. We all know it. In a world where a decade of specialized care for a vaccine-induced stroke can cost £1.5 million, a flat payment is an insult. But the "fix" being proposed—a sliding scale of payments based on need—is a regulatory disaster waiting to happen.
When you move from a flat-rate "consolation prize" to a needs-based "indemnity," you turn a fast-track administrative scheme into a slow-track litigation monster. Every claimant will need a forensic accountant, three medical experts, and five years of life-expectancy projections.
I’ve seen how these "reforms" play out in the corporate sector. When a firm tries to settle a mass tort by opening a flexible fund, the administrative costs eventually swallow 30% of the capital before a single victim sees a penny. The VDPS is already a black hole of bureaucracy; turning it into a bespoke compensation agency would be its final act of self-immolation.
The Causation Trap
The real battle isn't about the money. It’s about the science of "post hoc ergo propter hoc"—after this, therefore because of this.
Public health officials are terrified of the "Causation Creep." If the government admits that a specific case of Myocarditis or Guillain-Barré Syndrome was caused by the jab for the purposes of a payout, that admission becomes a weapon in every courtroom in the country. The VDPS was built to be a "no-fault" scheme to avoid this, yet it demands a level of "proof" that mimics a high-stakes negligence trial.
We need to stop pretending this is about clinical medicine and start admitting it's about political risk management. The Inquiry wants "transparency," but transparency in this context means exposing the fact that we don't have the diagnostic tools to definitively separate a vaccine injury from a background-rate health event in 90% of cases.
Stop Fixing the VDPS and Start Killing It
The contrarian solution isn't to "reform" the VDPS. It’s to abolish it and move the entire liability to the private sector—with a twist.
Currently, pharmaceutical giants enjoy a level of indemnity that would make a Victorian railroad tycoon blush. They have no "skin in the game" because the taxpayer is the insurer of last resort. This creates a moral hazard.
Imagine a scenario where vaccine manufacturers were required to contribute to a mandatory, industry-funded insurance pool, managed by independent actuaries rather than government bureaucrats.
- The Incentive Change: If the companies pay the premiums, they have a direct financial incentive to refine safety profiles faster than the regulators can track.
- The Speed: Private insurance is infinitely faster at processing claims than a government department that still uses paper files and legacy software.
- The Accountability: It removes the conflict of interest where the government is both the promoter of the vaccine and the judge of its side effects.
The Ethics of Mass Risk
We are told that vaccines are a "public good." That’s true. But the "lazy consensus" ignores the darker math: if a public good requires a small number of people to bear a catastrophic personal cost, that cost should be treated as a public debt, not a charitable donation.
The Inquiry’s focus on "urgent reform" is just code for "give them enough money to go away so we can stop talking about it." It ignores the people who don't fit the 60% disability bracket but whose lives have been derailed. The person who can no longer work a 40-hour week due to chronic fatigue but can still walk and feed themselves is invisible to the VDPS. They will remain invisible after the "reforms" because the system is designed to catch the falling, not support the stumbling.
The Brutal Reality of Payouts
Let’s talk about the money again. If the government actually compensated every Covid jab injury at the rate of a standard personal injury claim, the bill would run into the billions. The Treasury knows this. The Department of Health knows this.
This is why "reform" will always be a shell game. They will give an inch on the threshold and take a yard on the evidentiary requirements. They will increase the lump sum but make it harder to qualify.
The goal of the VDPS is not to make people whole. The goal is to maintain public confidence in the vaccination program at the lowest possible price point. If you understand that, you understand why the Inquiry’s recommendations are largely performative.
What Actually Works
If you are an individual suffering from a suspected injury, stop waiting for the VDPS to "fix itself." It is a graveyard of hope.
The only way to move the needle is through collective legal action that challenges the very definition of "no-fault." The system relies on individual claimants being too exhausted to fight. When 500 people with the same clinical presentation file simultaneously, the "rare" defense starts to crumble.
We also need to stop using the term "vaccine injury" as a political football. It is a biological reality. By making it a partisan issue, we’ve allowed the government to hide behind "anti-science" labels to avoid paying their debts.
The inquiry chair is asking the wrong questions. She’s asking how we can make a 45-year-old system slightly less cruel. We should be asking why we allow the government to be the sole arbiter of injuries caused by products it mandated and indemnified.
The system isn't an engine that needs a tune-up. It's a rusted-out hull that needs to be scrapped. Any "reform" that keeps the government as the judge, jury, and paymaster is just a new coat of paint on a sinking ship.
Stop asking for a better VDPS. Start demanding its total replacement with an industry-funded, strictly independent, and actuarially sound compensation model that doesn't treat victims like statistical errors.
The "fix" is a lie. The only way forward is to burn the old contract and write a new one where the risk follows the profit.
